Status:

RECRUITING

Biomarkers for Invasive Mucormycosis

Lead Sponsor:

University Hospital, Lille

Collaborating Sponsors:

Plateforme PAGés, Analyses Glycoconjugués

Région Hauts de France, France

Conditions:

Mucorales Infection

Mucormycosis

Eligibility:

All Genders

3-64 years

Brief Summary

Mucormycosis (MM) is one of the main invasive fungal infection (IFI), and is determined by filamentous fungi belonging to the order of Mucorales, with a mortality rate ranging from 20 to 60% according...

Eligibility Criteria

Inclusion

  • Men and women
  • Age : Children and adults from 3 to 64 years old (18 to 64 for controls)
  • In patients whose consent has been collected after information. In the case of children, information on the study will be given to the holders of parental authority and then to the child to obtain their consent.
  • Patient social insured
  • Specific medical conditions :
  • For the case group :
  • Any patient hospitalized in one of the departments of the University Hospital of Lille, in which the diagnosis of mucormycosis was conducted on the following criteria:
  • Conventional mycology data and / or
  • Positivity of q-PRC and / or
  • Anatomopathologic diagnosis Associated with a compatible clinical situation
  • For the control group 1 Patient assessed for hematopoietic stem cell transplantation, considered at risk for IFI but for whom the pre-transplantation review will have excluded an ongoing infection
  • For control group 2 Any patient hospitalized in a department of Lille University Hospital, in which the diagnosis of disseminated candidiasis or invasive pulmonary aspergillosis has been made according to specific classifications (EORTC/MSG criteria, AspICU criteria)

Exclusion

  • Patients for whom the inclusion criteria are not met
  • Co-infection mucormycosis/other IFI

Key Trial Info

Start Date :

November 29 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05406037

Start Date

November 29 2023

End Date

July 1 2026

Last Update

December 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Lille

Lille, Hauts-de-France, France, 59000